On-Ticagrelor Platelet Reactivity and Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome.
Marc LaineVassili PanagidesCorinne FrereThomas CuissetCaroline GouarneBernard JouveGilles LemesleFranck PaganelliMarie-Christine AlessiJulien ManciniLaurent BonelloPublished in: Thrombosis and haemostasis (2020)
On-ticagrelor PR measured by the VASP was not associated with bleeding or thrombotic events in ACS patients undergoing PCI. PR measured by the VASP should not be used as a surrogate endpoint in studies on ticagrelor.
Keyphrases